Neoantigenics Company

Neoantigenics is a liability company that focuses on developing oncology theranostics.

Investors

Industry: Women Cancer Treatment
Headquarters: Charlottesville, Virginia, United States
Funding Status: Seed
Total Funding: $2 536 862
Estimated Revenue: $1M to $10M
Last Funding Type: Seed
Visit Website
Register and Claim Ownership